These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3894034)

  • 1. Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000.
    Le Doussal V; Zangerle PF; Collette J; Spyratos F; Hacene K; Briere M; Franchimont P; Gest J
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):715-25. PubMed ID: 3894034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
    Mazoujian G; Pinkus GS; Davis S; Haagensen DE
    Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cyst fluid proteins and breast cancer.
    Zangerle PF; Spyratos F; Le Doussal V; Noel G; Hacene K; Hendrick JC; Gest J; Franchimont P
    Ann N Y Acad Sci; 1986; 464():331-49. PubMed ID: 3089095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic and functional aspects of apocrine metaplasia in dysplastic and neoplastic breast tissue.
    Bussolati G; Cattani MG; Gugliotta P; Patriarca E; Eusebi V
    Ann N Y Acad Sci; 1986; 464():262-74. PubMed ID: 3524352
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An immunohistochemical study of normal sweat glands using an antibody to the breast cyst fluid protein (GCDFP-15)].
    Komatsu T; Tajima S; Nishikawa T
    Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):985-9. PubMed ID: 2689726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
    Radhi JM
    Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoperoxidase localization of GCDFP-15 with mouse monoclonal antibodies versus rabbit antiserum.
    Mazoujian G; Parish TH; Haagensen DE
    J Histochem Cytochem; 1988 Apr; 36(4):377-82. PubMed ID: 3279111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apocrine epithelium of the breast: does it result from metaplasia?
    Viacava P; Naccarato AG; Bevilacqua G
    Virchows Arch; 1997 Sep; 431(3):205-9. PubMed ID: 9334842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical correlates of morphologic differentiation in human breast cancer.
    Silva JS; Cox CE; Wells SA; Paull D; Dilley WG; McCarty KS; Fetter BF; Glaubitz LC; McCarty KS
    Surgery; 1982 Sep; 92(3):443-9. PubMed ID: 7202259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study.
    Eusebi V; Betts C; Haagensen DE; Gugliotta P; Bussolati G; Azzopardi JG
    Hum Pathol; 1984 Feb; 15(2):134-40. PubMed ID: 6365733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.
    Selim AA; El-Ayat G; Wells CA
    Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions.
    Pasquinelli R; Barba P; Capasso I; D'Aiuto M; D'Aiuto G; Anzisi AM; De Berardinis P; Guardiola J
    Int J Cancer; 1999 Dec; 84(6):568-72. PubMed ID: 10567900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML; Longacre TA; Smoller BR
    Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
    Satoh F; Umemura S; Osamura RY
    Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ultrastructural localization of gross cystic disease fluid protein (GCDFP-15) in breast epithelium.
    Mazoujian G; Warhol MJ; Haagensen DE
    Am J Pathol; 1984 Aug; 116(2):305-10. PubMed ID: 6205595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
    Mazoujian G; Margolis R
    Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of GCDFP-15 expression in human fetal and adult normal tissues.
    Viacava P; Naccarato AG; Bevilacqua G
    Virchows Arch; 1998 Mar; 432(3):255-60. PubMed ID: 9532005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.